This study was conducted to compare the levels of IGF-1 and sclerostin in premenopausal women with and without diabetes, as they might be useful as markers of decreased bone formation in premenopausal women with type 2 diabetes. Here, IGF1 is linked to type 2 diabetes mellitus.